S/GHD fosters shared responsibility by supporting countries to coordinate donor nations, multilateral institutions, civil society, the private sector, faith-based organizations, foundations, and community members to strengthen overall investments in global health. S/GHD’s goal is to convene and work with U.S. Government agencies representing our interests in multilateral organizations to advance our global health priorities and improve and save more lives.
Examples of ways to champion shared responsibility:
In 2011, Cameroon recorded 23,152 cholera cases, with 843 deaths, representing a lethality rate of 3.6%. Working with the World Health Organization and the Ministry of Public Health, the Office of Foreign Disaster Assistance (OFDA) provided a $50,000 grant to establish and operate a Cholera Coordination and Control Center (C4) in Maroua, Far North Region, to gather data and respond quickly. The Commune of Foumbot in the West Region had the highest incidence of cholera. To address the situation there, in September 2011, the U.S. Embassy gave the International Federation of Red Cross Societies an $80,000 grant to construct a borehole and 100 latrines.
Uganda and Zambia:
Saving Mothers, Giving Life was launched in June 2012 to support countries where women are dying at alarming rates during pregnancy and childbirth to aggressively reduce maternal mortality. It represents a unique partnership involving the whole of the U.S. Government, the Government of Norway, Merck, the American College of Obstetricians and Gynecologists, and Every Mother Counts. Central to the effort are the Governments and local partners in Zambia and Uganda. Together, the founding partners have pledged more than $200 million USD in financial resources and additional in-kind resources to reduce maternal and newborn deaths in the developing world.
To advance country ownership of U.S. Government-supported programs in the HIV/AIDS sector in Botswana, a group of stakeholders developed a division of labor road map that identified five priority areas and determined actions to be undertaken by designated players, fostering shared responsibility and maximizing all partners’ investments.
CDC is a leading partner in the Measles and Rubella Initiative, which aims to achieve measles and rubella elimination in at least five WHO regions by 2020. The strategies used by the Initiative include: high vaccination coverage; monitoring spread of disease using laboratory-backed surveillance; outbreak preparedness and response and case management; communication and community engagement; and research and development. Facilitated in large part by CDC, the Initiative continues to expand, bringing together a large number of players, including the American Red Cross, the United Nations Foundation, UNICEF and the World Health Organization and the private sector.
Following a 2006 agreement that was signed between the U.S. Department of Health and Human Services and the Ministry of Science and Technology of China, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) began a collaboration with the Bureau of Health of Henan Province, China in 2009 to establish a joint TB research institute. On March 11, 2010, former Ambassador to China Jon Huntsman visited the joint research institute to kick off the start of the first clinical study to be conducted there. Complete with confetti cannons, this opening ceremony succeeded in raising the profile of the TB research institute with Henan provincial officials and was a very auspicious start to the research study. As the initial study was drawing to a close and preparations for the next study had begun, Ambassador Gary Locke visited the TB research institute as well. During Ambassador Locke’s visit, the China Ministry of Science and Technology (MOST) announced that it would match the $1 million USD that NIAID had already committed to the collaboration with another $1 million USD. The conduct of the 2nd clinical trial at the TB research center would not be possible without this funding commitment from MOST. The visits by Ambassadors Huntsman and Locke were both critically important in raising the profile of this joint TB research institute with provincial and national Chinese officials, allowing the research institute to be a success. Hopefully, this joint effort between United States and China could lead to exciting discoveries in TB and MDR TB research.
The U.S. will continue to lead efforts to strengthen the Global Fund, which leverages U.S. contributions almost 2.5 times with contributions from other donors.